StockGlow

Vertex Pharmaceuticals Incorporated (VRTX)

$473.09+0.00%
Market signal
80
Bullish
BearishBullish

The outlook

Vertex Pharmaceuticals is trading near the middle-to-upper portion of its 52-week range, with the price comfortably above both its 50- and 200-day moving averages. Analysts overwhelmingly favor the stock with a Buy consensus, and their average price target sits roughly 17% above the current level. The company trades at a trailing P/E of 28.0, reflecting a premium valuation typical of biotech firms with strong fundamentals.

What's behind the signal

Analyst consensusBuy — 1.7 avg of 23 analysts
Price trendAbove its 50- & 200-day averages
52-week range65% of the way from its 52-week low to high
Price targetAvg target +17% vs current price
Market cap
$120.07B
52-wk high
$533.67
52-wk low
$362.50
50-day avg
$463.72
200-day avg
$450.81
Trailing P/E
28.0

The “market signal” is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works